Bitcoin is showing signs of recovery with potential to reach $87,000 and possibly exceed $90,000, according to 21shares strategist Matt Mena. This outlook follows a softer-than-expected rise in U.S. producer prices, which eased selling pressure and encouraged buying around the $69,000 support level. However, if Bitcoin falls below $69,000, it could retest the $65,000 support. Despite recent sell-offs and ETF outflows, the strategist highlights Bitcoin's historical strong Q4 performance and rapid momentum shifts as reasons for cautious optimism.
Bitcoin's potential rebound to $90K and risk of a $65K retest provide context for cryptocurrency market activity on Pluang. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Nov 14, 2026 01:41 WIB: out of 50 major cryptocurrencies, 22 rose and 27 fell today. Ethereum (ETH) traded at Rp35.320.626 with a 1-day change of -3.79% and a typical hold time of 109 days, Uniswap (UNI) was at Rp105.181 with a -3.43% change, and The Graph (GRT) rose 3.37% to Rp321, though with 93% sell order activity.
Susan R. Burns, Ph.D., President of the University of Mount Saint Vincent, has been awarded the 2027 Courageous Leadership Award for her visionary and bold leadership. Since 2021, she has led the university through significant transformation, includi...
Solo, a company specializing in privacy-preserving human verification, has integrated its SDK into JellyJelly, a social video app co-founded by Venmo's co-founder. This integration ensures that every JellyJelly account belongs to a real, unique perso...
The U.S. market for AI-enabled ophthalmic diagnostic devices is projected to grow from $72.5 million in 2026 to $267.2 million by 2033, expanding at a 20.5% CAGR. Growth is driven by rising diabetes-related eye diseases, FDA clearances for autonomous...
The global medical display monitors market, valued at $2.8 billion in 2025, is projected to grow to $4.0 billion by 2033 with a CAGR of 4.6%. Growth is fueled by rising adoption of digital imaging systems, demand for accurate diagnostics, and healthc...
Oppenheimer downgraded Enovix from Outperform to Perform as the company expands production in South Korea and shifts focus to drone and smart-eyewear customers. Enovix reported a 38% revenue increase to $11 million in Q3 but saw its adjusted loss wid...
